Zimmer Biomet stock falls 1.31 percent despite higher 2026 guidance
Published on 09/25/2026 at 12:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Zimmer Biomet stock (ISIN US98956P1021) was quoted at USD 89.69 on the NYSE on September 24, 2026 at 4:00 p.m. ET, down 1.31 percent from USD 90.88. The key operating signal is fiscal 2026 guidance, which was raised after the second-quarter report.
Guidance moves higher for 2026
According to Zacks on September 16, 2026, Zimmer Biomet lifted its reported revenue growth outlook for fiscal 2026 to 3.9-4.9 percent from 2.5-4.5 percent. The company also raised adjusted EPS guidance to USD 8.47-8.59 from USD 8.40-8.55.
The guidance change matters because the stock has moved closer to the lower end of its 52-week range. The September 24 price stood USD 16.08 below the 52-week high of USD 106.88 and USD 10.57 above the low of USD 79.12.
Quarterly earnings beat estimates
Zimmer Biomet reported second-quarter 2026 adjusted EPS of USD 2.07 versus USD 2.01 consensus, a USD 0.06 beat, while revenue reached USD 2.18 billion against USD 2.13 billion expected. Zacks said on September 16, 2026 that revenue increased 4.8 percent year over year; GAAP EPS was USD 1.03 versus USD 0.77 in the prior-year quarter.
That combination gives investors two different signals: operating expectations improved, while the share price still trades below its yearly peak. Market capitalization stood at USD 17.35 billion and volume reached 2,612,812 shares on September 24, 2026.
Consensus target stays above price
According to MarketBeat on September 24, 2026, 22 brokerages assigned Zimmer Biomet a consensus Hold rating and an average price target of USD 103. The target is USD 13.31 above the September 24 price, leaving the guidance revision as the central test for a valuation that remains below the analyst average.
The company also declared a quarterly dividend of USD 0.24 per share. MarketScreener reported that the payment is scheduled for October 30, 2026, to shareholders of record on September 30, 2026.
Stock remains below its yearly high
Zimmer Biomet stock was quoted at USD 89.69 on the NYSE on September 24, 2026 at 4:00 p.m. ET. The USD 17.35 billion market capitalization and the 16.08 percent gap to the 52-week high frame the market reaction to higher fiscal 2026 guidance.
Zimmer Biomet stock facts
- Company: Zimmer Biomet Holdings, Inc.
- ISIN: US98956P1021
- Ticker: ZBH
- Trading venue: NYSE
- Price (as of September 24, 2026, 4:00 p.m. ET): USD 89.69
- Market capitalization: USD 17.35 billion (as of September 24, 2026)
- 52-week range: USD 79.12-106.88 (as of September 24, 2026)
- Sector / Industry: Healthcare / Medical Devices
